Answers are grounded in this paper and cite their sources.
Observational study shows lymphocyte levels predict efficacy and prognosis in esophageal cancer, implying optimal treatment management.
Pretreatmentment Lymphocytes ≥ 1.845 × 10⁹/L were found to have a good predictive effect on the PCR and RBCs < 4.31 × 10¹²/L were reflective of better tumor regression grades. Therefore, RBCs < 4.31 × 10¹²/L may serve as a surrogate marker of better prognosis in patients who have undergone nICT followed by esophagectomy.
No takes yet. Share an insight, caveat, or question.
Ran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: